Reaction
Abscess Drainage reporting signals
As of the last recalculation, Abscess Drainage appears in 850 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BIMEKIZUMAB (PRR 43.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bimekizumab | 36 | 43.2 | 43.2 |
| Infliximab-Dyyb | 26 | 22.4 | 22.5 |
| Meperidine Hydrochloride | 7 | 18.7 | 18.8 |
| Certolizumab Pegol | 42 | 9.2 | 9.2 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 4 | 5.4 | 5.4 |